NASDAQ:TMCI Treace Medical Concepts (TMCI) Stock Price, News & Analysis $5.34 +0.06 (+1.14%) (As of 10/4/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Treace Medical Concepts Stock (NASDAQ:TMCI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get TMCI alerts:Sign Up Key Stats Today's Range$5.26▼$5.4850-Day Range$5.01▼$7.4452-Week Range$3.92▼$15.98Volume212,100 shsAverage Volume613,481 shsMarket Capitalization$332.09 millionP/E RatioN/ADividend YieldN/APrice Target$7.30Consensus RatingHold Company OverviewTreace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.Read More… ⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Treace Medical Concepts Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks62nd Percentile Overall ScoreTMCI MarketRank™: Treace Medical Concepts scored higher than 62% of companies evaluated by MarketBeat, and ranked 416th out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingTreace Medical Concepts has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 6 hold ratings, and no sell ratings.Amount of Analyst CoverageTreace Medical Concepts has only been the subject of 3 research reports in the past 90 days.Read more about Treace Medical Concepts' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Treace Medical Concepts are expected to grow in the coming year, from ($0.93) to ($0.75) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Treace Medical Concepts is -6.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Treace Medical Concepts is -6.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTreace Medical Concepts has a P/B Ratio of 2.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Treace Medical Concepts' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.24% of the float of Treace Medical Concepts has been sold short.Short Interest Ratio / Days to CoverTreace Medical Concepts has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Treace Medical Concepts has recently increased by 3.68%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTreace Medical Concepts does not currently pay a dividend.Dividend GrowthTreace Medical Concepts does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted9.24% of the float of Treace Medical Concepts has been sold short.Short Interest Ratio / Days to CoverTreace Medical Concepts has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Treace Medical Concepts has recently increased by 3.68%, indicating that investor sentiment is decreasing. News and Social Media3.5 / 5News Sentiment1.32 News SentimentTreace Medical Concepts has a news sentiment score of 1.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Treace Medical Concepts this week, compared to 3 articles on an average week.Search Interest2 people have searched for TMCI on MarketBeat in the last 30 days. Company Ownership5.0 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Treace Medical Concepts insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,276,140.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders24.43% of the stock of Treace Medical Concepts is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.08% of the stock of Treace Medical Concepts is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Treace Medical Concepts' insider trading history. Receive TMCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter. Email Address TMCI Stock News HeadlinesTreace Medical Concepts, Inc. (NASDAQ:TMCI) CEO Buys 50,000 SharesSeptember 18, 2024 | insidertrades.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by BrokeragesOctober 5 at 4:43 AM | americanbankingnews.comHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash flow. Simply put, this time-tested 3-step strategy allows anyone to create cash flow from the stocks you already own without selling a single share in your portfolio. I call it "The Cash Flow Trade", and my team is going to teach you how and when to execute it in this free live event.October 6, 2024 | Unstoppable Prosperity (Ad)Treace Medical Concepts (TMCI) Slid on Reduced GuidanceSeptember 18, 2024 | finance.yahoo.comC$ dips as inflation data fuels BoC upsized rate cut talkSeptember 18, 2024 | ca.finance.yahoo.comTreace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024September 11, 2024 | globenewswire.comMaintaining Hold on Treace Medical Concepts Amidst Stable Growth and Anticipated Product LaunchesSeptember 7, 2024 | markets.businessinsider.comTreace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 22, 2024 | globenewswire.comSee More Headlines TMCI Stock Analysis - Frequently Asked Questions How have TMCI shares performed this year? Treace Medical Concepts' stock was trading at $12.75 at the start of the year. Since then, TMCI stock has decreased by 58.1% and is now trading at $5.34. View the best growth stocks for 2024 here. How were Treace Medical Concepts' earnings last quarter? Treace Medical Concepts, Inc. (NASDAQ:TMCI) released its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.34) EPS for the quarter, missing analysts' consensus estimates of ($0.29) by $0.05. The firm's revenue for the quarter was up 6.0% on a year-over-year basis. When did Treace Medical Concepts IPO? Treace Medical Concepts (TMCI) raised $150 million in an IPO on Friday, April 23rd 2021. The company issued 9,400,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Treace Medical Concepts' major shareholders? Top institutional shareholders of Treace Medical Concepts include SG Americas Securities LLC (0.04%). Insiders that own company stock include John T Treace, John R Treace, James T Treace, Thomas E Timbie, Richard W Mott, Sean F Scanlan, Deepti Jain, Daniel E Owens, Mark Hair, Scot Michael Elder, Aaron Berutti, F Barry Bays and Terry W Lubben. View institutional ownership trends. How do I buy shares of Treace Medical Concepts? Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings8/06/2024Today10/05/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:TMCI CUSIPN/A CIK1630627 Webwww.treace.com Phone904-373-5940FaxN/AEmployees250Year FoundedN/APrice Target and Rating Average Stock Price Target$7.30 High Stock Price Target$8.00 Low Stock Price Target$6.00 Potential Upside/Downside+36.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-49,530,000.00 Net Margins-32.08% Pretax Margin-32.08% Return on Equity-49.53% Return on Assets-26.50% Debt Debt-to-Equity Ratio0.47 Current Ratio3.86 Quick Ratio2.93 Sales & Book Value Annual Sales$187.12 million Price / Sales1.77 Cash FlowN/A Price / Cash FlowN/A Book Value$2.24 per share Price / Book2.38Miscellaneous Outstanding Shares62,190,000Free Float46,859,000Market Cap$332.09 million OptionableOptionable Beta0.20 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report This page (NASDAQ:TMCI) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash...Unstoppable Prosperity | SponsoredThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.